December 30, 2011 (Boston, MA) — Longer survival should not necessarily be expected from the use of preventive low-molecular-weight heparin (LMWH) in patients hospitalized with heart failure or other ...
The objective of our study was to determine the feasibility and safety of enoxaparin whole milligram dosing in premature and term neonates, and to assess response to treatment. Nineteen premature and ...
July 26, 2010 — The US Food and Drug Administration (FDA) has approved the first generic formulation of enoxaparin sodium injection (Sandoz, Inc; brand name, Lovenox; Sanofi-Aventis US, LLC), a ...
Despite thromboprophylaxis, major knee surgery carries a high risk of venous thromboembolism. Fondaparinux, the first of a new class of synthetic antithrombotic agents, may reduce this risk. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback